XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,155 $ 1,338
Accounts receivable, net of allowance of $496 and $587, respectively 105,295 124,069
Inventory 80,358 81,761
Other current assets 6,898 5,989
Total current assets 193,706 213,157
Property, plant and equipment, net 2,332,009 2,301,982
Operating lease right-of-use assets 14,343 14,097
Intangible assets, net 28,737 30,182
Contract costs, net 35,967 37,739
Deferred tax assets 2,847 3,192
Other assets 47,467 47,733
Non-current assets of discontinued operations 7,868 7,868
Total assets 2,662,944 2,655,950
Current liabilities:    
Accounts payable, trade 48,717 61,026
Accrued liabilities 98,751 85,381
Deferred revenue 5,778 5,736
Total current liabilities 153,246 152,143
Long-term debt 1,566,566 1,584,869
Operating lease liabilities 12,364 12,271
Deferred tax liabilities 15,986 4,921
Other liabilities 24,834 22,857
Non-current liabilities of discontinued operations 7,868 7,868
Total liabilities 1,780,864 1,784,929
Commitments and contingencies (Note 7)
Equity:    
Preferred stock: $0.01 par value per share, 50,000,000 shares authorized, zero issued
Common stock: $0.01 par value per share, 250,000,000 shares authorized, 165,775,863 and 164,984,401 shares issued, respectively 1,657 1,650
Additional paid-in capital 3,474,777 3,470,576
Accumulated deficit (2,485,399) (2,499,931)
Treasury stock: 9,489,406 and 9,020,454 common shares, at cost, respectively (108,955) (101,274)
Total equity 882,080 871,021
Total liabilities and equity $ 2,662,944 $ 2,655,950